BioArctic AB (FRA:B9A) Receivables Turnover: (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:B9A BioArctic AB FRA:B9A
77 GF Score
Price €28.34
GF Value €43.65
Valuation Possible Value Trap
! 7 Warning Signs
View Full Analysis

What is BioArctic AB Receivables Turnover?

The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. BioArctic AB's Revenue for the three months ended in Jun. 2026 was €22.73 Mil. BioArctic AB's average Accounts Receivable for the three months ended in Jun. 2026 was €0.00 Mil.


BioArctic AB  (FRA:B9A) Receivables Turnover Explanation

An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.


BioArctic AB Receivables Turnover Related Terms


BioArctic AB Receivables Turnover Historical Data

* Premium members only.

The historical data trend for BioArctic AB's Receivables Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

BioArctic AB Receivables Turnover Chart

BioArctic AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Receivables Turnover
Get a 7-Day Free Trial Premium Member Only Premium Member Only 8.27 77.84 2,679.38 7.21 20.69

BioArctic AB Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Receivables Turnover Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - 1.50 3.64 -

FRA:B9A vs VRTX, REGN, MRNA: Receivables Turnover Comparison

For the Biotechnology subindustry, BioArctic AB's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


BioArctic AB Receivables Turnover vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, BioArctic AB's Receivables Turnover distribution charts can be found below:

* The bar in red indicates where BioArctic AB's Receivables Turnover falls into.


FRA:B9A
77GF Score
BioArctic AB FRA:B9A
Receivables Turnover is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

BioArctic AB Receivables Turnover Calculation

Receivables Turnover measures the number of times a company collects its average accounts receivable balance.

BioArctic AB's Receivables Turnover for the fiscal year that ended in Dec. 2025 is calculated as

Receivables Turnover (A: Dec. 2025 )
=Revenue / Average Accounts Receivable
=Revenue (A: Dec. 2025 ) / ((Accounts Receivable (A: Dec. 2024 ) + Accounts Receivable (A: Dec. 2025 )) / count )
=180.61201432021 / ((6.2226115554555 + 11.235501903577) / 2 )
=180.61201432021 / 8.7290567295163
=20.69

BioArctic AB's Receivables Turnover for the quarter that ended in Jun. 2026 is calculated as

Receivables Turnover (Q: Jun. 2026 )
=Revenue / Average Accounts Receivable
=Revenue (Q: Jun. 2026 ) / ((Accounts Receivable (Q: Mar. 2026 ) + Accounts Receivable (Q: Jun. 2026 )) / count )
=22.733541136237 / (( + ) / 1 )
=22.733541136237 / 0
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Is BioArctic AB (FRA:B9A) Overvalued in 2026?

Based on GuruFocus' analysis, BioArctic AB stock appears to be undervalued. The current stock price of €28.34 is trading 35.1% below its estimated GF Value™ of €43.65. GuruFocus considers BioArctic AB to be Possible Value Trap.

Key valuation signals for FRA:B9A:

  • Receivables Turnover:
  • GF Value™: €43.65 vs. price of €28.34 (35.1% below fair value)
  • GF Score™: 77/100 with 7 warning signs

No single metric tells the full story. See the FRA:B9A stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


BioArctic AB Business Description

Address Warfvinges vag 35, Stockholm, SWE, SE-112 51
BioArctic AB is a research-based biopharmaceutical company focusing on disease-modifying treatments and diagnostics for neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease, and ALS. Geographically, it derives a majority of its revenue from North America.
77GF Score

Get the complete analysis for FRA:B9A

Receivables Turnover is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€28.34
Price
€43.65
GF Value